newsfilter
← Latest News
Business Wire·

Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that members of its senior